May 27, 2014

Pharma is on the Competition Bureau's radar

Andrew Skodyn was quoted in this article in the June/July Issue of Canadian Lawyer InHouse, which first appeared on

"The Competition Bureau is honing in on the pharmaceutical sector, amid concern about alleged market distortions caused by legal settlements and industry practices.

At a conference held last November in Delhi, India, the bureau submitted a paper highlighting the huge significance of the Canadian health care system to the national economy and to residents' well-being..."